Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/12/2012EP2496264A1 Composition for promoting wound healing
09/12/2012EP2496262A2 Stabilized protein formulations and use thereof
09/12/2012EP2496259A1 Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
09/12/2012EP2496252A1 Production of recombinant factor ix in a human hepatocyte cell line
09/12/2012EP2496251A1 Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract
09/12/2012EP2496250A1 Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry
09/12/2012EP2496249A2 Glp-1 receptor agonist compounds for obstructive sleep apnea
09/12/2012EP2496248A2 Method for treating heart failure with stresscopin-like peptides
09/12/2012EP2496247A1 Methods for treating fatty liver disease
09/12/2012EP2496246A2 Composition, method, and kit for alpha-1 proteinase inhibitor
09/12/2012EP2496245A2 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
09/12/2012EP2496244A2 Drug resistant immunotherapy for treatment of a cancer
09/12/2012EP2496243A2 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
09/12/2012EP2496213A2 Pharmaceutical solution of non covalently bound albumin and acylated insulin
09/12/2012CN102666845A Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methods
09/12/2012CN102666844A Glycosyl transferase from Chinese hamster and related methods
09/12/2012CN102666843A Wo2011079073
09/12/2012CN102666581A Methods and compositions for the inhibition of transplant rejection
09/12/2012CN102666580A Glycosylated form of antigenic GLP-1 analogue
09/12/2012CN102666576A Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
09/12/2012CN102665765A Composition for promoting wound healing
09/12/2012CN102665756A Method of treatment of philadelphia chromosome positive leukaemia
09/12/2012CN102665754A Immunomodulating polypeptides derived from IL-2 and use thereof in cancer and chronic infections
09/12/2012CN102665753A Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients
09/12/2012CN102665752A Oxyntomodulin peptide analogue
09/12/2012CN102665751A Anti-androgenic agent, sebum secretion blocker, hair growth stimulant, and food or beverage
09/12/2012CN102665750A Nutritional composition beneficial to small intestine
09/12/2012CN102665749A Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
09/12/2012CN102665748A Inhibition 0f inflammation using antagonists of MUC1
09/12/2012CN102665691A Formulation for hGH and rhIGF-1 combination
09/12/2012CN102665690A Sustained-release formulation
09/12/2012CN102665682A Pharmaceutical compositions comprising igf-1 proteins, a buffering and a tonicity agent
09/12/2012CN102665676A Pharmaceutical solution of non-covalently bound albumin and acylated insulin
09/12/2012CN102665446A Nutritional formulation comprising a cow's milk peptide-containing hydrolysate and/or peptides derived thereof for tolerance induction
09/12/2012CN102660617A Application of alga used for preparing angiotensin converting enzyme inhibitor
09/12/2012CN102660580A Construction method of SOD (superoxide dismutase) gene modified mesenchymal stem cell and application thereof
09/12/2012CN102660569A Method for preparing recombinant human IgE receptor protein and application of recombinant human IgE receptor protein
09/12/2012CN102660548A Preparation and application of South China sea conus textile conotoxin TxO10
09/12/2012CN102660529A Pepsin intensifier, pepsin composition and application of pepsin intensifier
09/12/2012CN102660523A Low-immunogenicity lumbrukinase, preparation method and application thereof
09/12/2012CN102660491A Gene engineering bacteria high-efficiently expressing recombined human glucagon-like peptide-1 (1-37) and construction method and application thereof
09/12/2012CN102659951A TAT (Trans-activating factor) kringle domain-modified nenurogenin2 fusion protein, as well as preparation method thereof and application thereof
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659938A Glucagon-like-peptide-2 (GLP-2) analogues
09/12/2012CN102659932A Lipopeptid and derivative thereof, and preparation methods and application of lipopeptid and derivative of lipopeptid
09/12/2012CN102659930A High-purity cyclopeptide crystal and its preparation method and use
09/12/2012CN102659926A Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea
09/12/2012CN102659922A Peptide Derived From Hepatitis C Virus
09/12/2012CN102659920A C-end phenylalanine p-amino modified endomorphine-1 analog and preparation and application thereof
09/12/2012CN102657875A ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof
09/12/2012CN102657871A Oral slow release preparation, entrapment material and preparation method
09/12/2012CN102657866A Cancer prevention and fighting capsules
09/12/2012CN102657865A Method for conveying proteins or antigens to mammal intestinal tract in targeted way by using transgenic coccidian
09/12/2012CN102657852A Medical composition of recombinant Wautersiella asparaginase and preparation method and application thereof
09/12/2012CN102657851A Recombinant human interferon alpha2b cream and preparation method thereof
09/12/2012CN102657850A Sustained-release tissue engineering membrane loaded with transforming growth factor beta 3 (TGF-beta3)
09/12/2012CN102657849A Application of toad maggot protein in medicine used for treating cervical cancer
09/12/2012CN102657848A Application of toad maggot protein in medicine used for treating colon cancer
09/12/2012CN102657847A Application of toad maggot protein in medicine used for treating rectal cancer
09/12/2012CN102657846A Compound traditional Chinese medicine active ingredient preparation used for treating leukemia and production method thereof
09/12/2012CN102657845A Applications of odorrana grahami polypeptide AH90 and CW49 for promoting skin regeneration
09/12/2012CN102657844A Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
09/12/2012CN102657843A Antibacterial peptide composition and preparation method thereof
09/12/2012CN102657842A Medicinal composition with function of increasing bone density and application thereof
09/12/2012CN102657612A GDNF-carrying microbubble preparation and method for making the same
09/12/2012CN102657599A Method for preparing bioactive injectable hydrogel materials for oncotherapy
09/12/2012CN102241674B Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester
09/12/2012CN102219860B FGFR-Fc fusion protein and applications thereof
09/12/2012CN102219859B Fusion protein for antagonizing angiogenesis inducible factor and application thereof
09/12/2012CN102166187B Recombinant human endostatin sustained-release injection oil preparation and preparation process thereof
09/12/2012CN101891800B Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof
09/12/2012CN101869699B Preparation process of bone peptide soft capsule
09/12/2012CN101628110B Use of fungal immunomodulatory protein
09/12/2012CN101579522B Novel peptide-based vaccine used for domestic animal and preparation method thereof
09/12/2012CN101410131B Lipid-metabolism-improving agent
09/12/2012CN101325965B Use of transferrins for treating destructive inflammation of mucous membrane
09/12/2012CN101090730B Composition and method for increasing apoptosis in cancer cells
09/12/2012CN101007851B Chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
09/11/2012US8263761 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
09/11/2012US8263756 Injecting aqueous solution containing an expression vector comprising desired gene; gene therapy wherein hepatocyte growth factor (HGF) gene is introduced by electroporation into kidney to be transplanted
09/11/2012US8263747 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/11/2012US8263739 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
09/11/2012US8263738 Estrogen receptors and methods of use
09/11/2012US8263654 Compositions and methods for skin treatment
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263582 Administering two separate dosage forms of a topically active corticosteroid or a pharmaceutically active salt thereof for therapy ofinflammatory bowel disease and sufficient to reduce or eliminate side effects
09/11/2012US8263573 Delivery of dsRNA to arthropods
09/11/2012US8263563 Furin inhibitors
09/11/2012US8263562 Peptides for preventing or treating liver damage
09/11/2012US8263561 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
09/11/2012US8263560 HPV 16 peptide vaccine for head and neck cancer
09/11/2012US8263559 Feline granulocyte macrophage colony stimulating factor proteins
09/11/2012US8263558 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
09/11/2012US8263557 Method and mixture for in vivo photochemical cross-linking of collagen
09/11/2012US8263556 Suppressive macrophages, C-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic
09/11/2012US8263555 Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
09/11/2012US8263554 Methods of using GLP-1 receptor agonists to treat pancreatitis
09/11/2012US8263553 Neublastin variants
09/11/2012US8263552 Glucagon-like-peptide-2 (GLP-2) analogues
09/11/2012US8263551 Soluble, stable insulin-containing formulations with a protamine salt
1 ... 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 ... 3163